EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Differential Genetic Effects on Statin-Induced Changes Across Low-Density Lipoprotein–Related Measures

Audrey Y. Chu, Franco Giulianini, Bryan J. Barratt, Bo Ding, Fredrik Nyberg, Samia Mora, Paul M. Ridker, Daniel I. Chasman

Circulation: Cardiovascular Genetics · 2015-10 · 8 (5) · 688-695

DOI: 10.1161/circgenetics.114.000962 ↗
AbstractBibliografische Angaben

Abstract

Background— Statin therapy influences not only low-density lipoprotein (LDL) cholesterol levels but also LDL-related biomarkers, including non–high-density lipoprotein cholesterol (non–HDL-C), apolipoprotein B, total number of LDL particles, and mean LDL particle size. Recent studies have identified many genetic loci influencing circulating lipid levels and statin-induced LDL cholesterol reduction. However, it is unknown how these genetic variants influence statin-induced changes in LDL subfractions and non–HDL-C. Methods and Results— One hundred sixty candidate single-nucleotide polymorphisms for effects on circulating lipid levels or statin-induced LDL-cholesterol lowering were tested for association with response of LDL subfractions and non–HDL-C to rosuvastatin or placebo for 1 year among 7046 participants from the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial. Of the 51 single-nucleotide polymorphisms associated with statin response for ≥1 of the LDL subfractions or non–HDL-C, 20 single-nucleotide polymorphisms could be clustered according to effects predominantly on LDL particle size, predominantly on LDL particle number, and on apolipoprotein B but not on LDL cholesterol or non–HDL-C. Conclusions— These differential associations point to pathways of LDL response to statin therapy and possibly to mechanisms of statin-dependent cardiovascular disease risk reduction. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifier: NCT00239681.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →